Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023
Tuberculosis Disease Severity Assessment Using Clinical Variables and Radiology Enabled by Artificial Intelligence
Marwan Ghanem1, Ratnam Srivastava1, Yasha Ektefaie1
1Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Background:
Chest X-ray (CXR) can assess pulmonary tuberculosis (TB) severity and may guide duration of treatment. However, the optimal radiological metric and its integration with clinical variables for predicting treatment outcomes remains unclear.
Methods:
We used logistic regression to associate human-read and commercial artificial intelligence-generated CXR metrics with unfavorable outcome in the TB Portals real-world dataset (n = 2809). We assessed the standalone predictive accuracy for each of 10 radiological features for unfavorable outcomes, and combined the best-performing features with other clinical data. We fine-tuned ensembles of convolutional neural nets (CNNs) to automate human-read percent of lung involved (PLI) measurement directly from CXR images (n = 5261).
Results:
Human-read PLI is the only CXR finding associated with outcome across drug resistance and human immunodeficiency virus (HIV) subgroups and is optimally combined with age, sex, and smear grade for predicting treatment outcome. PLI predicts outcomes better than cavitation (area under the curve [AUC], 0.654 vs 0.581, respectively), performs better than all tested Qure.ai automated features (qXR v2), and improves outcome prediction when added to sex + age + smear grade (ΔAUC, 0.028 [95% confidence interval, .007-.042]). The CNN ensemble for predicting PLI >25% achieves an AUC of 0.850.
Conclusions:
PLI performs better than cavitation as a radiological marker for predicting TB treatment outcome, and improves risk stratification when combined with key clinical variables. Automation of PLI can be predicted using CNNs to enable scalability and accurate assessment.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
